https://www.selleckchem.com/products/ly333531.html
When comparing primary outcomes between African-Americans to non-African-Americans, there was no statistical significant difference in mortality rate and recurrent stroke rate between the two groups. CONCLUSION This study found no statistical significant difference in the incidence of recurrent stroke and mortality between mono antiplatelet therapy and dual antiplatelet therapy among patients who had ischemic stroke or TIA; with similar findings in a subgroup analysis comparing outcomes in African-American patients compared to non-Afri
Curtir
Comentario
Compartilhar
